Ensuring Compliance Against Drug Diversion Act of 2021
USA117th CongressHR-1899| House
| Updated: 11/10/2021
H. Morgan Griffith
Republican Representative
Virginia
Cosponsors (1)
Judiciary Committee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee, Budget Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Ensuring Compliance Against Drug Diversion Act of 2021 This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances. It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Mr. Pallone moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H1764-1765)
DEBATE - The House proceeded with forty minutes of debate on H.R. 1899.
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Considered as unfinished business. (consideration: CR H1832)
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 5 (Roll no. 113). (text: 04/14/2021 CR H1764)
View VoteMotion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Passed Senate without amendment by Unanimous Consent.
Senate Committee on the Judiciary discharged by Unanimous Consent.(consideration: CR S7391)
Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S7391)
Message on Senate action sent to the House.
Presented to President.
Signed by President.
Became Public Law No: 117-53.
Crime and Law Enforcement
Administrative law and regulatory proceduresDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrations
Ensuring Compliance Against Drug Diversion Act of 2021
USA117th CongressHR-1899| House
| Updated: 11/10/2021
Ensuring Compliance Against Drug Diversion Act of 2021 This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances. It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Mr. Pallone moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H1764-1765)
DEBATE - The House proceeded with forty minutes of debate on H.R. 1899.
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Considered as unfinished business. (consideration: CR H1832)
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 5 (Roll no. 113). (text: 04/14/2021 CR H1764)
View VoteMotion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Passed Senate without amendment by Unanimous Consent.
Senate Committee on the Judiciary discharged by Unanimous Consent.(consideration: CR S7391)
Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S7391)
Message on Senate action sent to the House.
Presented to President.
Signed by President.
Became Public Law No: 117-53.
H. Morgan Griffith
Republican Representative
Virginia
Cosponsors (1)
Judiciary Committee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee, Budget Committee
Crime and Law Enforcement
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrations